Interferon-induced transmembrane proteins as biomarkers for assessing the diagnosis and severity of coronary artery disease and acute myocardial infarction
IFITM1/2/3 may serve as novel serum biomarkers for diagnosing CAD and AMI, as well as stratifying coronary stenosis severity, with high discriminatory capacity. Our findings position IFITMs as promising tools for precision cardiovascular risk assessment and therapeutic targeting.
Authors
- Xiaoqi Zheng (ORCID: https://orcid.org/0000-0002-1832-4404)
- Qingyan Huang (ORCID: https://orcid.org/0000-0002-3902-5382)
- Xiaoyan Tang (ORCID: https://orcid.org/0000-0003-1640-1661)
- Junxing Zhu
- Mingfeng Huang
- Yuhong Gan (ORCID: https://orcid.org/0009-0009-0240-7983)
- Shaobin Zhi
Institutions
- Meizhou City People's Hospital (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-11-24
- DOI
- https://doi.org/10.3389/fmed.2025.1645725
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00